Anlon Healthcare Board to Approve Q1 FY27 Results, Share Swap

Board Meeting Details

• Meeting Date: Thursday, July 30, 2026
• Location: Registered office of the company

Agenda Items

1. Financial Results Approval: To consider and approve the Unaudited Standalone and Unaudited Consolidated Financial Results of the Company for the Quarter ended June 30, 2026 along with the Limited Review of Auditors thereon.

2. Share Swap Authorization: To authorize Mr. Punitkumar Rasadia (Chairman & Managing Director) and/or Mr. Meet Vachhani (Whole Time Director) for:

• Entering into share swap arrangement with shareholders of Apiqo Organics Private Limited (AOPL) and Bizotic LifeScience Private Limited (BLPL)
• Acquiring 32.52% shareholding in AOPL
• Acquiring 43.33% shareholding in BLPL
• Making both entities wholly owned subsidiaries
• Consideration: Issuance and allotment of fresh equity shares of the Company on preferential basis for consideration other than cash to selling shareholders

3. Other Business: Any other business with permission of the Chair

Recipients

• BSE Limited, Listing Department, Mumbai
• National Stock Exchange of India Limited, Listing Department, Mumbai